IND-enabling services
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
IND-enabling services
-
Narrated by:
-
By:
The Food and Drug Administration’s Investigational New Drug( IND) program is the method that which a pharmaceutical company is granted permission to transport an experimental drug over states (usually to clinical researchers) before the time a marketing request for the drug is approved. The FDA evaluates the IND-enabling services. For safety to ensure that research subjects are not placed at risk in any way. When the application has been approved the drug candidate typically is placed in an initial clinical trial.
adbl_web_anon_alc_button_suppression_t1
No reviews yet